Characterization of the Mouse Islet-Specific Glucose-6-Phosphatase Catalytic Subunit–Related Protein Gene Promoter by In Situ Footprinting
Correlation With Fusion Gene Expression in the Islet-Derived βTC-3 and Hamster Insulinoma Tumor Cell Lines
- Larry J. Bischof1,
- Cyrus C. Martin1,
- Christina A. Svitek1,
- Beth T. Stadelmaier1,
- Lauri A. Hornbuckle1,
- Joshua K. Goldman1,
- James K. Oeser1,
- John C. Hutton2 and
- Richard M. O’Brien1
- 1Department of Molecular Physiology and Biophysics, Vanderbilt University Medical School, Nashville, Tennessee
- 2Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado
Abstract
Glucose-6-phosphatase (G6Pase) is a multicomponent system located in the endoplasmic reticulum comprising a catalytic subunit and transporters for glucose-6-phosphate, inorganic phosphate, and glucose. We have recently cloned a novel gene that encodes an islet-specific G6Pase catalytic subunit–related protein (IGRP) (Ebert et al., Diabetes 48:543–551, 1999). To begin to investigate the molecular basis for the islet-specific expression of the IGRP gene, a series of truncated IGRP–chloramphenicol acetyltransferase (CAT) fusion genes were transiently transfected into the islet-derived mouse βTC-3 and hamster insulinoma tumor cell lines. In both cell lines, basal fusion gene expression decreased upon progressive deletion of the IGRP promoter sequence between −306 and −66, indicating that multiple promoter regions are required for maximal IGRP-CAT expression. The ligation-mediated polymerase chain reaction footprinting technique was then used to compare trans-acting factor binding to the IGRP promoter in situ in βTC-3 cells, which express the endogenous IGRP gene, and adrenocortical Y1 cells, which do not. Multiple trans-acting factor binding sites were selectively identified in βTC-3 cells that correlate with regions of the IGRP promoter identified as being required for basal IGRP-CAT fusion gene expression. The data suggest that hepatocyte nuclear factor 3 may be important for basal IGRP gene expression, as it is for glucagon, GLUT2, and Pdx-1 gene expression. In addition, binding sites for several trans-acting factors not previously associated with islet gene expression, as well as binding sites for potentially novel proteins, were identified.
- CAT, chloramphenicol acetyltransferase
- DMEM, Dulbecco’s modified Eagle’s medium
- DTT, dithiothreitol
- GSD, glycogen storage disease
- G6P, glucose-6-phosphate
- G6Pase, glucose-6-phosphatase
- HNF, hepatocyte nuclear factor
- IGRP, islet-specific G6Pase catalytic subunit–related protein
- LMPCR, ligation-mediated polymerase chain reaction
- MUT, mutant
- PBS, phosphate-buffered saline
- PCR, polymerase chain reaction
- TBE, 89 mmol/l Tris + 89 mmol/l boric acid + 2 mmol/1 EDTA
- WT, wild type
Footnotes
-
Address correspondence and reprint requests to Richard M. O’Brien, PhD, Department of Molecular Physiology and Biophysics, 761 MRB II, Vanderbilt University Medical School, Nashville, TN 37232-0615. E-mail: richard.obrien{at}mcmail.vanderbilt.edu.
Received for publication 12 July 2000 and accepted in revised form 25 October 2000.
R.M.O’B. is a paid consultant for Oncogene Science, Inc.














